Saturday, September 22, 2012

Saving Tomato Seeds

Saving Tomato Seeds
and
Zucchini and the .357 Target Practice



What happens to a zucchini when shot with a .357? In this video, we discuss all kinds of things from saving tomato seeds to planting a whole tomato right in the ground. Yes, we planted a whole, vine-ripened tomato right in the ground and covered it with grass clippings. Crazy? Maybe...unless it works...then everyone will start doing it. Oh yea. Don't forget...we answer the question: What happens to a zucchini when shot with a .357 hand gun?

Saving seeds use to be a mystery to me. However, in recent years I have come to realize that if someone else can do it, so can I. Sure, there are a few limitations; as a 42-year-old over-weight nurse, my chances for piloting the space shuttle are slim to none. Saving seeds will be a mission here on earth that I will be successful with.

Have you ever heard of The Self Sufficient Homestead? The couple who produce their podcast also has a seed trading site that is FREE to use. Here is the link to the seed site: http://www.heirloomseedswap.com/

The link to the Self Sufficient Homestead is: http://www.sshomestead.com/

Here are a few links:

2 comments:

  1. Dasatinib treatment of chronic myeloid leukemia markedly

    A clinical study results, published in the 48th Annual Meeting of the American Society of Hematology (ASH) recently held Nepal resistant or intolerant chronic myeloid leukemia (CML) in chronic phase patients with imatinib updasatinib (dasatinib) treatment, can achieve hematologic and cytogenetic response, and the lasting effect.

    This open, multi-center international clinical study, a group of patients taking dasatinib 70 mg per day, taken twice; another group of patients taking imatinib, the dose was increased to 800 mg per day (two efficacy and safety in patients with previous underwent daily 400 to 600 mg of imatinib). The data analysis shows that after 3 months of treatment and 15 months, the dasatinib-treated patients to achieve and maintain the number of patients with major cytogenetic response from 36% to 53%, higher than the imatinib group . The difference was statistically significant.

    Dasatinib is the first FDA-approved oral multi-targeted kinase inhibitor can be combined with the BCR-ABL kinase multiple conformation for the treatment of the past (including the use of imatinib) treatment failure or intolerance various stages of adult patients with CML, including the chronic phase, accelerated phase, and myeloid cells or lymphocytes blastic phase.



    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    Tandutinib
    KW-2449
    Quizartinib
    AST 487
    Linifanib
    Canertinib
    Canertinib dihydrochloride
    CP-724714 (E-Double bond)
    2-Methoxyestradiol
    GSK1904529A

    ReplyDelete
  2. Drug treatment of CLL paying off navitoclax

    Seymour Phase Ⅱ clinical study analyzed the drug navitoclax (apoptosis regulatory proteins Bcl-2 inhibitor targeting high affinity) for 27 patients with relapsed chronic lymphocytic leukemia (CLL) efficacy, patients were treated prior to high intensity treatment, in the median age was 70 years, up until disease progression or intolerance. The results show that, navitoclax does have clinical efficacy in patients with objective response rate was 33%, 19 cases of peripheral blood lymphocyte count decreased> 50%, 12 cases were treated with adenovirus reduced more than 50% the size of lymph nodes.



    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    RAF265
    Sunitinib Malate
    Vandetanib
    PD173074
    Regorafenib
    Brivanib alaninate
    Brivanib
    SU 5402
    TSU-68
    Tivozanib

    ReplyDelete